Atlas Trials

Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions

Clinical trial NCT03685409 · UNKNOWN

Trial details

NCT number
NCT03685409
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Oral Cancer
Start date
2018-10-01
Primary completion
2019-09-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.